Literature DB >> 33706572

Effects of repetitive transcranial magnetic stimulation (rTMS) on aphasia in stroke patients: A systematic review and meta-analysis.

Jun Zhang1, Dongling Zhong1, Xili Xiao2, Li Yuan3, Yuxi Li4, Yaling Zheng5, Juan Li1, Tianyu Liu6, Rongjiang Jin1.   

Abstract

OBJECTIVE: To evaluate the effects and safety of repetitive transcranial magnetic stimulation (rTMS) on aphasia in stroke patients.
METHODS: We searched databases from inception to January 28, 2021. Randomized control trials investigating the effects and safety of rTMS for aphasia patients after stroke were included. Study screening, data extraction, and risk of bias assessment were performed independently by two reviewers. Meta-analysis was conducted with Review Manager 5.3 software. The quality of the evidence was assessed by the Grading of Recommendations Assessment, Development, and Evaluation (GRADE).
RESULTS: Twenty-eight studies with 1287 patients were included. All studies were assessed at low or unclear risk of bias in one or more domains. The meta-analysis exhibited rTMS was better than sham rTMS and conventional rehabilitation in language recovery. Low-frequency rTMS showed greater improvement in language recovery except for comprehension than sham rTMS. Low-frequency and bilateral rTMS were superior to conventional rehabilitation in language recovery. High-frequency rTMS was no better than sham rTMS and conventional rehabilitation for improving aphasia. The rTMS had better effects in naming, comprehension and aphasia quotient at 20 sessions. Eleven studies reported rTMS was safe for aphasia patients after stroke. The quality of evidence for all outcomes was low or very low, and publication bias may exist.
CONCLUSIONS: rTMS may be relatively effective and safe for aphasia patients after stroke. However, these findings should be treated with caution due to high heterogeneity and potential biases.

Entities:  

Keywords:  Aphasia; meta-analysis; repetitive transcranial magnetic stimulation; stroke; systematic review

Mesh:

Year:  2021        PMID: 33706572     DOI: 10.1177/0269215521999554

Source DB:  PubMed          Journal:  Clin Rehabil        ISSN: 0269-2155            Impact factor:   3.477


  6 in total

1.  Study on Low-Frequency Repetitive Transcranial Magnetic Stimulation Improves Speech Function and Mechanism in Patients With Non-fluent Aphasia After Stroke.

Authors:  Guangtao Bai; Liang Jiang; Sai Huan; Pingping Meng; Yuyang Wang; Xiaona Pan; Shuai Yin; Yuyang Zhao; Qiang Wang
Journal:  Front Aging Neurosci       Date:  2022-05-30       Impact factor: 5.702

Review 2.  Transcranial magnetic stimulation for post-operative neurorehabilitation in neuro-oncology: a review of the literature and future directions.

Authors:  Evan H Einstein; Nicholas B Dadario; Hamza Khilji; Justin W Silverstein; Michael E Sughrue; Randy S D'Amico
Journal:  J Neurooncol       Date:  2022-03-25       Impact factor: 4.130

3.  The multidimensional nature of aphasia recovery post-stroke.

Authors:  James D Stefaniak; Fatemeh Geranmayeh; Matthew A Lambon Ralph
Journal:  Brain       Date:  2022-05-24       Impact factor: 15.255

4.  The optimum parameters and neuroimaging mechanism of repetitive transcranial magnetic stimulation to post-stroke cognitive impairment, a protocol of an orthogonally-designed randomized controlled trial.

Authors:  Ling-Xin Li; Jing-Kang Lu; Bao-Jin Li; Qiang Gao; Cheng-Qi He; Shi-Hong Zhang; You-Jin Zhao; Shuai He; Qian Wen
Journal:  PLoS One       Date:  2022-07-21       Impact factor: 3.752

5.  Can Transcranial Electrical Stimulation Facilitate Post-stroke Cognitive Rehabilitation? A Systematic Review and Meta-Analysis.

Authors:  Ahsan Khan; Kai Yuan; Shi-Chun Bao; Chun Hang Eden Ti; Abdullah Tariq; Nimra Anjum; Raymond Kai-Yu Tong
Journal:  Front Rehabil Sci       Date:  2022-02-10

Review 6.  Reversing the Ruin: Rehabilitation, Recovery, and Restoration After Stroke.

Authors:  Melissa D Stockbridge; Lisa D Bunker; Argye E Hillis
Journal:  Curr Neurol Neurosci Rep       Date:  2022-10-01       Impact factor: 6.030

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.